The GPR35–Na/K-ATPase–Src pathway is precisely targetable with GPR35-selective pepducins.10 Its upstream role in tumour tissue remodelling renders GPR35 an attractive target, even in cases where tumour cells themselves do not express the receptor. This evidence concerns the gene GPR35 and neoplasm.